A - Agilent Technologies - Stock & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US00846U1016
Spectrometers, Chromatographs, Analyzers, Instruments, Software, Automation
Agilent Technologies Inc. is a leading provider of application-focused solutions to the life sciences, diagnostics, and applied chemical markets globally. The company operates through three distinct segments, each catering to specific industries and customer needs.
The Life Sciences and Applied Markets segment is a comprehensive platform that offers a wide range of products and solutions, including liquid chromatography systems, mass spectrometry systems, gas chromatography systems, inductively coupled plasma mass spectrometry instruments, and atomic absorption instruments. Additionally, this segment provides cell analysis plate-based assays, flow cytometers, real-time cell analyzers, cell imaging systems, microplate readers, laboratory software, information management and analytics, laboratory automation and robotic systems, dissolution testing, and vacuum pumps, as well as measurement technologies.
The Diagnostics and Genomics segment is focused on genomics, nucleic acid contract manufacturing, and research and development, pathology, companion diagnostics, reagent partnerships, and biomolecular analysis businesses. This segment is dedicated to providing innovative solutions for the diagnostics and genomics industries, enabling customers to make breakthrough discoveries and improve human health.
The Agilent CrossLab segment is a one-stop-shop for laboratory essentials, offering GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies. This segment also provides a comprehensive services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services, ensuring that customers have access to the support they need to optimize their laboratory operations.
Agilent Technologies markets its products and solutions through a diverse range of channels, including direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. With a strong global presence, the company is well-positioned to serve customers in various regions and industries.
Founded in 1999, Agilent Technologies is headquartered in Santa Clara, California, and has established itself as a trusted partner for scientists, researchers, and laboratory professionals worldwide. For more information, please visit https://www.agilent.com.
Drawdown (Underwater) Chart
Overall Trend and Yearly Seasonality
A Stock Overview
Market Cap in USD | 39,890m |
Sector | Healthcare |
Industry | Diagnostics & Research |
GiC SubIndustry | Life Sciences Tools & Services |
TER | 0.00% |
IPO / Inception | 1999-11-18 |
A Stock Ratings
Growth 5y | 50.6 |
Fundamental | 36.5 |
Dividend | 28.5 |
Rel. Performance vs Sector | 0.79 |
Analysts | 3.65/5 |
Fair Price Momentum | 135.88 USD |
Fair Price DCF | 123.03 USD |
A Dividends
Dividend Yield 12m | 0.69% |
Yield on Cost 5y | 1.30% |
Dividends CAGR 5y | 6.27% |
Payout Consistency | 63.1% |
A Growth Ratios
Growth 12m | 25.93% |
Growth Correlation 12m | 51.5% |
Growth Correlation 3m | 52.4% |
CAGR 5y | 13.55% |
CAGR/Mean DD 5y | 0.83 |
Sharpe Ratio 12m | 0.77 |
Alpha vs SP500 12m | -11.07 |
Beta vs SP500 5y weekly | 0.90 |
ValueRay RSI | 18.29 |
Volatility GJR Garch 1y | 25.85% |
Price / SMA 50 | -2.83% |
Price / SMA 200 | -0.85% |
Current Volume | 966.5k |
Average Volume 20d | 1370.7k |
External Links for A Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of October 22, 2024, the stock is trading at USD 136.76 with a total of 966,462 shares traded.
Over the past week, the price has changed by -5.19%, over one month by -2.22%, over three months by +2.67% and over the past year by +30.34%.
According to ValueRays Forecast Model, A Agilent Technologies will be worth about 149.7 in October 2025. The stock is currently trading at 136.76. This means that the stock has a potential upside of +9.47%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 148 | 8.20 |
Analysts Target Price | 135.8 | -0.74 |
ValueRay Target Price | 149.7 | 9.47 |